Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Changchun Deng, MD, PhD

Changchun Deng, MD, PhD

  • Specialty: Hematology and Oncology
    View Expertise
  • Primary Location: 11100 Euclid Ave (0 mi.)
    Other Locations
  • Languages Spoken: Chinese, English

Office Locations

UH Seidman Cancer Center (0 mi.)

11100 Euclid Ave
1st Floor
Cleveland, OH 44106
216-844-3951

Biography: Changchun Deng, MD, PhD

Expertise

  • Chronic Lymphocytic Leukemia (CLL/SLL)
  • Lymphoma (Hodgkin and non-Hodgkin, B- and T-cell)

Titles

  • Medical Director, Lymphoma and CLL, UH Seidman Cancer Center
  • Associate Professor, CWRU School of Medicine

Certifications & Memberships

  • Hematology - American Board of Internal Medicine

Education

Fellowship | Hematology/Oncology
Hematology/Oncology - New York-Presbyterian/Columbia University Medical Center (2008 - 2010)

Fellowship | Hematology/Oncology
Hematology/Oncology - University Of Texas Southwestern Medical Center (2007 - 2008)

Residency | Internal Medicine
Internal Medicine - Lincoln Medical And Mental Health Center (2004 - 2007)

Research Fellowship | Radiation Oncology
Radiation Oncology - Stanford University (2001 - 2004)

Other Education | Molecular Biology
Molecular Biology - University Of Pittsburgh (1994 - 2001)

Medical Education
Suzhou Medical College (1990)

Featured Videos

Watch to find out more about this University Hospitals provider.

Patient Experience Reviews

4.9 out of 5
- based on 97 Ratings
(5)
10/1/2024

*** My doctor is very good but the support staff is utterly lacking in professionalism.

(5)
10/1/2024

No issues.

(5)
10/1/2024

All good ***

(5)
9/1/2024

Wonderful and caring doctor who listens to the patient and gives one all the time they need!

(5)
9/1/2024

I was in the hospital and this was a follow up visit. Why does it take so long to get the results the doctor needs to set up the care the patient needs to get better. I am still waiting for biopsy results after almost two weeks.Additionally everyone should be able to discuss your care. I was told numerous times the person, nurse I was being called by they would have to check and call me back. I didn't always get a call back,.Also if the patient is given an after visit summary it should be correct.Good doctor, my complaints are with the process.

(5)
8/1/2024

Explained what future treatment might be depending on what the PET scan would show. He prepared me and saw my positive reaction.

(5)
8/1/2024

Exceptional experience with the whole process. I am switching my primary care to UH because of this experience. Thank you for being amazing

(5)
8/1/2024

Dr deng is absolutely awesome

(5)
8/1/2024

Everyone was very helpful and polite. Would recommend this hospital to everyone. Very pleased with Dr. Deng.

(5)
6/1/2024

Excellent experience.

(5)
4/1/2024

I am satisfied and happy the care I received.

(5)
3/1/2024

Dr. Deng and his team were professional, knowledgeable and respectful.

(5)
1/1/2024

My experience was very positive. The news was not a happy one for me. All staff were completely pleasant and helpful. I have no complaints. ***

(5)
12/1/2023

Each time, I waited an hour in exam room after arriving for appointment. After 50 minutes, a staff member informed the doctor would finish up soon

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Changchun Deng did not disclose any Outside Relationships with Industry.